Related Experiment Video

Updated: Aug 19, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

The oncoprotein I-2PP2A/SET negatively regulates the MEK/ERK pathway and cell proliferation

Chikako Fukukawa1, Hiroshi Shima, Nobuhiro Tanuma

  • 1Division of Biochemical Oncology and Immunology, Institute for Genetic Medicine, Hokkaido University, Sapporo 060-0815, Japan.

International Journal of Oncology
|February 11, 2005
PubMed

Insights

The protein I-2PP2A/SET inhibits cell proliferation by blocking the G1/S transition and the MEK/ERK pathway. This suggests I-2PP2A/SET may act as a tumor suppressor, regulating cell growth.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • I-2PP2A/SET is a protein encoded by a translocation breakpoint found in acute undifferentiated leukemia.
  • It functions as an inhibitor of protein phosphatase 2A (PP2A).

Purpose of the Study:

  • To investigate the role of I-2PP2A/SET in cell proliferation and its mechanism of action.
  • To determine if I-2PP2A/SET acts as a tumor suppressor.

Main Methods:

  • Overexpression of I-2PP2A/SET in cells.
  • siRNA-mediated depletion of I-2PP2A/SET.
  • Cell cycle analysis (G1/S transition).
  • Analysis of the MEK/ERK signaling pathway activation.

Main Results:

  • Exogenous I-2PP2A/SET suppressed cell proliferation, while its depletion enhanced it.
  • Depletion of I-2PP2A/SET led to a decrease in G1 phase cells and an increase in S phase cells.
  • I-2PP2A/SET suppressed ERK activation following EGF stimulation but did not affect JNK or p38.
  • Knockdown of I-2PP2A/SET enhanced ERK and MEK activation, indicating negative regulation of the MEK/ERK pathway.

Conclusions:

  • I-2PP2A/SET negatively regulates cell growth by inhibiting the G1/S transition.
  • I-2PP2A/SET inhibits the MEK/ERK pathway, which is stimulated by external stimuli.
  • These findings suggest I-2PP2A/SET has potential tumor suppressor functions.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.